Literature DB >> 9249024

Evidence for the existence of multiple heparan sulfate proteoglycans in the human glomerular basement membrane and mesangial matrix.

A J Groffen1, F W Hop, K Tryggvason, H Dijkman, K J Assmann, J H Veerkamp, L A Monnens, L P Van den Heuvel.   

Abstract

Heparan sulfate proteoglycans (HSPGs) are essential components of the glomerular basement membrane (GBM) carrying a strong anionic charge. A well-characterized extracellular HSPG is perlecan, ubiquitously expressed in basement membranes. A cDNA construct encoding domains I and II of human perlecan was expressed as a fusion protein with glutathione S-transferase. This fusion protein was used to generate monoclonal antibody 95J10. We compared the staining pattern of 95J10 with that of M215, a previously prepared mAb that recognizes HSPG isolated from human GBM. In kidney cortex, the anti-perlecan mAb 95J10 showed a strong staining of the mesangium, Bowman's capsule, the tubular basement membrane, and stained the GBM only slightly. In contrast, M215 predominantly stained the GBM in a linear fashion. Immunoelectron microscopy supported these results, showing concentrations of perlecan in some regions of the GBM, whereas the unidentified M215 antigen was homogenously distributed throughout the GBM. In other human tissues, both antibodies also produced a different staining pattern. Furthermore, a polyclonal antiserum recognizing HSPG isolated from the GBM did not recognize perlecan from EHS tumors. These results provide evidence for the presence of another HSPG in the GBM that is immunologically distinct from perlecan. The absence of perlecan splice variants in the kidney suggests that this component is encoded by a different gene than perlecan. Given its marked expression in the GBM, this component could be a determining factor in the maintenance of selective glomerular permeability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249024     DOI: 10.1111/j.1432-1033.1997.00175.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

Authors:  Simone A Joosten; Mieneke G A van Dixhoorn; Maria C Borrias; Hallgrimur Benediktsson; Peter A van Veelen; Cees van Kooten; Leendert C Paul
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

Review 2.  Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.

Authors:  Dorin-Bogdan Borza
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

Review 3.  The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.

Authors:  Kevin J McCarthy; Deborah J Wassenhove-McCarthy
Journal:  Microsc Microanal       Date:  2012-02       Impact factor: 4.127

4.  Heparan sulfate gene polymorphism in calcium oxalate nephrolithiasis.

Authors:  Metin Onaran; Akin Yilmaz; Ilker Sen; Mehmet Ali Ergun; Ahmet Camtosun; Bora Küpeli; Sevda Menevse; Ibrahim Bozkirli
Journal:  Urol Res       Date:  2008-12-09

Review 5.  Basement Membrane Defects in Genetic Kidney Diseases.

Authors:  Christine Chew; Rachel Lennon
Journal:  Front Pediatr       Date:  2018-01-29       Impact factor: 3.418

Review 6.  Biological roles of glycans.

Authors:  Ajit Varki
Journal:  Glycobiology       Date:  2016-08-24       Impact factor: 4.313

Review 7.  Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease.

Authors:  María M Adeva-Andany; Natalia Carneiro-Freire
Journal:  World J Diabetes       Date:  2022-07-15

8.  Differential expression of parietal epithelial cell and podocyte extracellular matrix proteins in focal segmental glomerulosclerosis and diabetic nephropathy.

Authors:  Gek Cher Chan; Diana G Eng; Jeffrey H Miner; Charles E Alpers; Kelly Hudkins; Anthony Chang; Jeffrey W Pippin; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2019-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.